z-logo
Premium
Omega 3/6 fatty acids for reading in children: a randomized, double‐blind, placebo‐controlled trial in 9‐year‐old mainstream schoolchildren in Sweden
Author(s) -
Johnson Mats,
Fransson Gunnar,
Östlund Sven,
Areskoug Björn,
Gillberg Christopher
Publication year - 2017
Publication title -
journal of child psychology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.652
H-Index - 211
eISSN - 1469-7610
pISSN - 0021-9630
DOI - 10.1111/jcpp.12614
Subject(s) - placebo , placebo controlled study , randomization , randomized controlled trial , psychology , medicine , pediatrics , physical therapy , double blind , alternative medicine , pathology
Background Previous research has shown positive effects of Omega 3/6 fatty acids in children with inattention and reading difficulties. We aimed to investigate if Omega 3/6 improved reading ability in mainstream schoolchildren. Methods We performed a 3‐month parallel, randomized, double‐blind, placebo‐controlled trial followed by 3‐month active treatment for all subjects. Mainstream schoolchildren aged 9–10 years were randomized 1:1 to receive three Omega 3/6 capsules twice daily or identical placebo. Assessments were made at baseline, 3 months, and 6 months. The primary outcome measure was the Logos test battery for evaluating reading abilities. The trial is registered with ClinicalTrials.gov, number NCT 02557477. Results The study enrolled 154 children (active n  = 78; placebo n  = 76), of whom 122 completed the first 3 months (active n  = 64; placebo n  = 58) and 105 completed the whole study (active/active n  = 55; placebo/active n  = 50). Outcomes were assessed by per protocol ( PP ) and intention‐to‐treat ( ITT ) analyses. Active treatment was superior to placebo at 3 months for improvement in phonologic decoding time ( PP active/placebo difference −0.16; 95% CI −0.03, −0.29; effect size ( ES ) .44; p  = .005; and ITT ES .37; p  = .036), in visual analysis time ( PP active/placebo difference −0.19; 95% CI −0.05, −0.33; ES .49; p  = .013; and ITT ES .40; p  = .01), and for boys in phonologic decoding time ( PP −0.22; 95% CI −0.03, −0.41; ES .62; p  = .004). Children with ADHD ‐ RS scores above the median showed treatment benefits in visual analysis time ( PP ES .8, p  = .009), reading speed per word ( PP ES .61, p  = .008), and phonologic decoding time per word ( PP ES .85, p  = .006). Adverse events were rare and mild, mainly stomach pain/diarrhea (active n  = 9, placebo n  = 2). Conclusions Compared with placebo, 3 months of Omega 3/6 treatment improved reading ability – specifically the clinically relevant ‘phonologic decoding time’ and ‘visual analysis time’ – in mainstream schoolchildren. In particular, children with attention problems showed treatment benefits.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom